Teladoc Health, Inc.
TDOC
$9.11
$0.182.02%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -3.03% | -2.99% | -1.53% | 2.68% | 3.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.03% | -2.99% | -1.53% | 2.68% | 3.58% |
| Cost of Revenue | -2.32% | -3.34% | -1.30% | 2.33% | 2.41% |
| Gross Profit | -3.33% | -2.85% | -1.62% | 2.84% | 4.07% |
| SG&A Expenses | 5.78% | -4.24% | -7.78% | 1.15% | -4.03% |
| Depreciation & Amortization | -8.20% | -5.02% | 27.96% | 40.28% | 28.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.13% | -5.27% | -2.78% | 4.46% | 3.04% |
| Operating Income | -40.90% | 30.99% | 16.67% | -22.23% | 7.58% |
| Income Before Tax | -89.84% | 45.44% | -1,160.85% | -15.54% | 99.33% |
| Income Tax Expenses | -93.23% | 131.40% | 507.98% | 295.01% | 290.93% |
| Earnings from Continuing Operations | -67.56% | 41.70% | -1,185.22% | -18.29% | 99.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.56% | 41.70% | -1,185.22% | -18.29% | 99.24% |
| EBIT | -40.90% | 30.99% | 16.67% | -22.23% | 7.58% |
| EBITDA | -73.01% | 1.70% | 600.57% | -1.89% | 106.90% |
| EPS Basic | -61.03% | 43.87% | -1,139.50% | -14.90% | 99.26% |
| Normalized Basic EPS | -133.95% | 48.61% | 24.59% | -13.08% | 41.19% |
| EPS Diluted | -61.03% | 43.87% | -1,139.50% | -14.90% | 99.26% |
| Normalized Diluted EPS | -133.95% | 48.61% | 24.59% | -13.08% | 41.19% |
| Average Basic Shares Outstanding | 4.04% | 3.86% | 3.69% | 2.95% | 2.40% |
| Average Diluted Shares Outstanding | 4.04% | 3.86% | 3.69% | 2.95% | 2.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
